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Drastic reduction of sarcalumenin in Dp427 (dystrophin of
427 kDa)-deficient fibres indicates that abnormal calcium
handling plays a key role in muscular dystrophy
Paul DOWLING, Philip DORAN and Kay OHLENDIECK1
Department of Biology, National University of Ireland, Maynooth, County Kildare, Ireland
Although the primary abnormality in dystrophin is the underlying
cause for mdx (X-chromosome-linked muscular dystrophy), ab-
normal Ca2+ handling after sarcolemmal microrupturing appears
to be the pathophysiological mechanism leading to muscle weak-
ness. To develop novel pharmacological strategies for eliminating
Ca2+-dependent proteolysis, it is crucial to determine the fate
of Ca2+-handling proteins in dystrophin-deficient fibres. In
the present study, we show that a key luminal Ca2+-binding
protein SAR (sarcalumenin) is affected in mdx skeletal-muscle
fibres. One- and two-dimensional immunoblot analyses revealed
the relative expression of the 160 kDa SR (sarcoplasmic reti-
culum) protein to be approx. 70% lower in mdx fibres when
compared with normal skeletal muscles. This drastic reduction
in SAR was confirmed by immunofluorescence microscopy.
Patchy internal labelling of SAR in dystrophic fibres suggests an
abnormal formation of SAR domains. Differential co-immuno-
precipitation experiments and chemical cross-linking demon-
strated a tight linkage between SAR and the SERCA1 (sarco-
plasmic/endoplasmic-reticulum Ca2+-ATPase 1) isoform of the
SR Ca2+-ATPase. However, the relative expression of the fast
Ca2+ pump was not decreased in dystrophic membrane pre-
parations. This implies that the reduction in SAR and cal-
sequestrin-like proteins plays a central role in the previously
reported impairment of Ca2+ buffering in the dystrophic SR
[Culligan, Banville, Dowling and Ohlendieck (2002) J. Appl.
Physiol. 92, 435–445]. Impaired Ca2+ shuttling between the
Ca2+-uptake SERCA units and calsequestrin clusters via SAR,
as well as an overall decreased luminal ion-binding capacity,
might indirectly amplify the Ca2+-leak-channel-induced increase
in cytosolic Ca2+ levels. This confirms the idea that abnormal
Ca2+ cycling is involved in Ca2+-induced myonecrosis. Hence,
manipulating disturbed Ca2+ handling might represent new modes
of abolishing proteolytic degradation in muscular dystrophy.
Key words: calcium handling, Dp427 (dystrophin of 427 kDa),
dystrophin, muscular dystrophy, sarcalumenin.
INTRODUCTION
Ca2+ ions are involved in the fine regulation of numerous physio-
logical processes. The highly organized interactions between Ca2+
channels, Ca2+-sequestrating proteins and Ca2+ pumps maintain
the precise temporal and spatial control of Ca2+ fluxes, Ca2+
buffering and Ca2+ uptake [1]. The importance of Ca2+ handling
for signal transduction has been well established for muscle
tissues [2]. Ca2+ cycling through the SR (sarcoplasmic reticulum)
regulates the contractile status of skeletal-muscle fibres, making
Ca2+ ions key second-messenger molecules of the excitation–
contraction–relaxation cycle [3]. In mdx (X-chromosome-linked
muscular dystrophy), a neuromuscular disorder caused by the
primary deficiency in the membrane cytoskeletal protein Dp427
(dystrophin of 427 kDa) [4], abnormal Ca2+ handling has been
postulated to play a major role in the secondary steps leading to
fibre necrosis [5]. It is well established that the primary deficiency
in dystrophin and the secondary reduction in the dystrophin-
associated glycoprotein complex lead to an impaired linkage
between the actin membrane cytoskeleton and the extracellular
matrix component LAM (laminin) [6,7]. Loss of sarcolemmal
integrity is believed to render the muscle periphery more
susceptible to microrupturing [8], thereby allowing for the in-
sertion of Ca2+-leak channels into the sarcolemma during the
natural processes of cell-membrane resealing [5].
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gradient; mAb, monoclonal antibody; LAM, laminin; mdx, X-chromosome-linked muscular dystrophy; SAR, sarcalumenin; SERCA, sarcoplasmic/endo-
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Although the recent analysis of transgenic mdx muscles exhibit-
ing an overexpression of utrophin suggests that mechanosensitive
Ca2+ channels are not the initial triggering factors of the dystrophic
process [9], their presence clearly gives rise to localized Ca2+
increases near the sarcolemma [10]. This contributes a cycle
of enhanced protease activity and Ca2+-leak channel activation
[11]. The pathophysiological modification of ion-regulatory
surface elements may precede the increased Ca2+-leak channel
activation, which is then followed by downstream alterations in the
intracellular Ca2+-handling apparatus. Recent studies suggest
the involvement of Ca2+-permeable growth-factor-regulated
channels [12] and transient receptor potential channels [13] in
Ca2+ fluxes through the dystrophic sarcolemma. In contrast,
the involvement of the voltage-sensing dihydropyridine receptor
of the transverse tubules [14] or potential abnormalities in the
formation of the Ca2+-release channel complex [15] have been
excluded as major factors in muscular dystrophy.
On the basis of a recent survey of the fate of Ca2+-regula-
tory membrane proteins in dystrophin-deficient muscle mem-
branes [16], we have extended our immunoblot analysis to
the Ca2+-binding element SAR (sarcalumenin) [17]. Within the
SR lumen, loss of the CLPs [CSQ (calsequestrin)-like proteins]
[16], indicative of impaired CSQ clustering [18], may contribute
to decreased luminal Ca2+ buffering. This probably amplifies
the increased free cytosolic Ca2+ levels. In analogy, abnormal
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expression patterns of other luminal Ca2+-binding proteins might
also be involved in this process. SAR of 160 kDa apparent mass
binds approx. 35 mol of Ca2+ ions per mol of protein and is
located in both the longitudinal tubules and the terminal cisternae
region of the SR [19]. SAR is expressed at comparable levels
in predominantly slow- and fast-twitching muscle fibres [20].
Although almost all key Ca2+-regulatory membrane proteins un-
dergo isoform switching after chronic low-frequency stimulation
[21], the relative expression levels of SAR are not altered during
stimulation-induced fast- to slow-fibre transitions [20].
mAb (monoclonal antibody) XIIC4 to SAR recognizes 53-
SRGP (SR glycoprotein of 53 kDa) in addition to the main
160 kDa band [22]. The 53 kDa protein does not bind Ca2+ ions
and represents an alternative splice variant of the C-terminal part
of the SAR gene [17]. Comparative immunoelectron microscopy
has demonstrated that both proteins co-localize with the SR
Ca2+-ATPase [19]. Studies by Shoshan-Barmatz et al. [23,24]
suggest that cycles of phosphorylation and dephosphorylation of
SAR and HRC (histidine-rich Ca2+-binding protein) modulate
the activity of the junctional ryanodine receptor Ca2+-release
channel complex. In addition, other endogenous regulators of
the ryanodine receptor are represented by triadin and CSQ [25].
The present study demonstrates that SAR is reduced in dystro-
phic SR vesicles, supporting the previous observation that
dystrophic fibres exhibit impaired luminal Ca2+ buffering [16], in
addition to increased cytosolic Ca2+ levels [5,10,11]. Furthermore,
the idea that disturbed ion homoeostasis is a key pathobiochemical
factor that triggers Ca2+-induced myonecrosis agrees with recent
studies showing that the pharmacological elimination of Ca2+-
dependent proteolysis counteracts dystrophic changes in muscle
cells [26,27].
MATERIALS AND METHODS
Materials
Ultrapure Protogel acrylamide stock solutions were obtained from
National Diagnostics (Atlanta, GA, U.S.A.) and protease inhib-
itors from Roche Diagnostics (Mannheim, Germany). Chemi-
luminescence substrates and the Seize-XTM Protein A immuno-
precipitation kit were purchased from Perbio Science U.K.
(Tattenhall, Cheshire, U.K.). Protran nitrocellulose membranes
were obtained from Schleicher and Schuell (Dassel, Germany)
and IPG (immobilized pH gradient) strips (pH 3–10) and IPG
buffer (pH 3–10) from Amersham Biosciences (Little Chalfont,
Bucks., U.K.). The cationic carbocyanine dye ‘Stains All’,
the DNA-binding dye DAPI (4,6-diamidino-2-phenylindole) and
DNase I were purchased from Sigma (Poole, Dorset, U.K.).
Primary antibodies were obtained from Affinity Bioreagents
[Golden, CO, U.S.A.; mAb XIIC4 to SAR, mAb IIH11 to
the fast SERCA1 (sarcoplasmic/endoplasmic-reticulum Ca2+-
ATPase 1) isoform of the Ca2+-ATPase and mAb VIIID12 to CSQ],
Sigma (polyclonal antibody to LAM), Upstate Biotechnology
[Lake Placid, NY, U.S.A.; mAb C464.6 to the α1-subunit of the
Na+/K+-ATPase and mAb VIA41 to α-DG (α-dystroglycan)] and
Novacastra Laboratories [Newcastle upon Tyne, U.K.; mAb NCL-
43 to β-DG (β-dystroglycan) and mAb DYS-2 to the C-terminus
of the Dp427 isoform of dystrophin]. Antibodies to Up395
(utrophin of 395 kDa) and HRC were gifts from Dr S. Winder
(University of Sheffield, U.K.) and Dr W. J. Park (Kwangju
Institute of Science, Kwangju, Korea) respectively. Peroxidase-,
rhodamine- or fluorescein-conjugated secondary antibodies were
obtained from Chemicon (Temecula, CA, U.S.A.) and Superfrost
Plus positively charged microscope slides were from Menzel
Gla¨sser (Braunschweig, Germany). All other chemicals used were
of analytical grade and purchased from Sigma.
Dystrophic muscle specimens
The mdx mouse model of Duchenne muscular dystrophy [28]
is characterized by the absence of the Dp427 isoform of the
membrane cytoskeletal element dystrophin owing to a point
mutation in exon 23 [29]. We obtained 6-, 8- and 24-week-old
male mice of the Dmdmdx strain (Jackson Laboratory, Bar Harbor,
ME, U.S.A.) and age-matched controls from the Biomedical
Facility of the National University of Ireland (Dublin, Ireland).
To compare the expression of SAR in normal versus mdx
skeletal muscles, tissue specimens were prepared for (i) deter-
gent extraction of the total muscle protein complement to per-
form one- and two-dimensional immunoblot analyses, (ii) subcel-
lular fractionation to perform immunoblotting of the SR-enriched
microsomal fraction, and (iii) cryosectioning for immunofluore-
scence localization studies. For immunoblot analysis, skeletal-
muscle samples were quick-frozen in liquid nitrogen, transferred
to a container with solid CO2 and stored at − 70 ◦C before homo-
genization. For immunofluorescence microscopy, muscle speci-
mens were carefully dissected and immediately quick-frozen in
liquid nitrogen-cooled isopentane, transferred to a container with
solid CO2 and stored at − 70 ◦C before cryosectioning.
Two-dimensional gel electrophoresis of total muscle extracts
The abundance of SAR in crude muscle extracts was determined
by one-dimensional immunoblot analysis and two different
two-dimensional techniques. One-dimensional immunoblot ana-
lysis and diagonal non-reducing/reducing two-dimensional gel
electrophoresis were performed as described previously [30,31].
Two-dimensional electrophoresis with IEF (isoelectric focusing)
in the first dimension was specifically optimized for the separation
of muscle proteins. Before IEF, whole muscle sections (0.2 g
wet weight) were ground to a fine powder using liquid nitrogen
and subsequently solubilized in lysis buffer containing 9.5 M
urea, 4% (w/v) Chaps, 0.5% (v/v) carrier ampholytes 3–
10 and 100 mM DTT (dithiothreitol). To avoid protein degra-
dation, the solution was supplemented with a freshly prepared
protease inhibitor cocktail [0.2 mM pefabloc, 1.4 µM pepstatin,
0.15 µM aprotinin, 0.3 µM trans-epoxysuccinyl-L-leucylamido-
(4-guanidino)butane (‘E-64’), 1 µM leupeptin, 0.5 mM soya-
bean trypsin inhibitor and 1 mM EDTA]. To eliminate the
excessive viscosity of the extract due to DNA, 2 µl of DNase I
(200 units) was added per 100 µl of lysis buffer. After
incubation at room temperature (20 ◦C) for 3 h (whereby samples
were vortex-mixed every 10 min for 5 s), the suspension was
centrifuged at 20 000 g for 20 min at 4 ◦C in an Eppendorf
5417R centrifuge (Hamburg, Germany). The supernatant was
diluted in IPG-strip lysis buffer [complemented with 0.05%
(w/v) Bromophenol Blue tracking dye] to achieve a final protein
concentration of 50 µg of protein/IEF strip for silver staining
or immunoblotting. IEF was performed on individual 7-cm-
long IPG strips at 60 µA/strip using an IPGphor IEF system
obtained from Amersham Biosciences. The run conditions were
as follows: a 30 V step for 12 h, 200 V for 1 h, 500 V for 1 h,
1000 V for 1 h, 2000 V for 1 h, 4000 V for 2 h and, finally,
6000 V for 6 h [32]. After IEF, the cover fluid was poured off
and the strips were stored at − 70 ◦C until further use. Before
separation in the second-dimension gel system, focused strips
were equilibrated for 30 min in a solution of 30% (w/v) glycerol,
20% (w/v) sucrose, 3% (w/v) SDS, 6 M urea, 50 mM Tris/HCl
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(pH 8.8) and 100 mM DTT, and a further 30 min equilibration
was performed employing 250 mM iodoacetamide instead of
100 mM DTT. After equilibration, the strips were embedded in
an agarose solution containing 0.5% (w/v) agarose in standard
SDS electrophoresis buffer [25 mM Tris/192 mM glycine,
pH 8.3/0.1% (w/v) SDS]. Second-dimension electrophoresis
was performed with a 7.5% (w/v) separation gel for 210 Vh
[33]. Silver staining, immunoblotting and enhanced chemilumin-
escence were performed by standard methodology [30]. Den-
sitometric scanning of enhanced chemiluminescence blots was
performed on a Molecular Dynamics 300S computing densito-
meter (Sunnyvale, CA, U.S.A.) using ImageQuant V3.0 software.
Differences between means were evaluated using an unpaired
two-sided Student’s t test, where P < 0.05 was considered to be
significant. Labelling of Ca2+-binding elements with the cation-
ic carbocyanine dye ‘Stains All’ was performed by the method
of Campbell et al. [34].
Biochemical analysis of microsomes
For immunoblotting, ‘Stains All’ labelling, chemical cross-link-
ing and differential co-immunoprecipitation analysis of the SR
from normal and dystrophic muscles, the microsomal fraction was
isolated by an established method at 0–4 ◦C [35] in the presence of
the protease inhibitor cocktail described above. The membranes
were resuspended at a protein concentration of 10 mg/ml and
then used immediately for gel electrophoretic separation and bio-
chemical analyses. Protein concentration was determined by the
method of Bradford [36], using BSA as a standard. A Mini-
MP3 electrophoresis system and a mini blotting cell, obtained
from Bio-Rad Laboratories (Hemel Hempstead, Herts., U.K.),
were used for the one-dimensional gel electrophoretic separation
of microsomal muscle proteins under reducing conditions. We
used 7% (w/v) resolving gels and 25 µg of protein/lane. Micro-
somal proteins were electrophoretically transferred for 1 h at
100 V on to nitrocellulose membranes. Incubation with anti-
bodies, visualization of immunodecorated protein bands and
densitometric scanning of developed immunoblots were per-
formed as described previously in detail [30]. Chemical cross-
linking of muscle-membrane proteins using the hydrophobic
1.2 nm probe, DTSP [dithiobis(succinimidyl propionate)], was
performed by an established method [35]. Cross-linker-stabilized
complexes, as indicated by DTSP-induced shifts to lower electro-
phoretic mobilities, were determined by immunoblot analysis
of non-reducing gels. Immunoprecipitation experiments were
performed as described by Culligan et al. [16].
Immunofluorescence microscopy
Cryosections of 12 µm thickness were prepared on a Microm
cryostat (Heidelberg, Germany) and mounted on to Superfrost
Plus positively charged microscope slides. After fixation and
blocking [16], sections were incubated with primary antibodies,
carefully washed and then incubated with fluorescein- or rhoda-
mine-conjugated secondary antibodies. Images were obtained
by an established methodology [16]. To outline the cellular
periphery in cryosections labelled with antibodies to SAR, fibres
were double-stained for the surface marker LAM. For double
immunostaining, a mixture of the two primary antibodies was
applied to the muscle sections for 1 h at 37 ◦C. Subsequently,
cryosections were washed and then separately incubated, for
30 min each, with a differently conjugated secondary antibody.
Internal SAR staining with a fluorescein probe and LAM labelling
with a rhodamine-conjugated antibody were performed. For
labelling the position of nuclei within fibres, cryosections were
incubated with the DNA-binding dye DAPI [18].
RESULTS
Reduced expression of SAR in mdx skeletal muscles
On the basis of recent findings that luminal Ca2+ sequestration
is significantly reduced in dystrophin-deficient fibres [16] and
that the oligomerization of the terminal cisternae Ca2+-binding
protein, CSQ, is impaired in mdx skeletal muscles [18], the present
study investigated potential changes in another abundant luminal
SR Ca2+-binding element, namely the 160 kDa protein SAR
[17]. Although certain biochemical analyses of relatively low-
abundance proteins can be performed properly only with enriched
vesicular preparations, it cannot be excluded that extensive
subcellular fractionation procedures may introduce artifacts.
Therefore, before performing a more detailed immunoblotting
survey, chemical cross-linking studies and differential co-
immunoprecipitation experiments of microsomal membranes, we
first analysed the total muscle protein complement by one- and
two-dimensional electrophoresis. As shown in Figure 1, the
expression of SAR is significantly reduced in dystrophic mdx
muscles when compared with age-matched control specimens.
In contrast with relatively comparable levels of the Na+/K+-
ATPase (Figures 1A and 1C) and 53-SRGP (Figures 1B and
1E), immunodecoration of the 160 kDa SAR band revealed an
approx. 70% decrease in density in mdx muscle (Figures 1B and
1D). Immunoblotting of nitrocellulose replicas after diagonal non-
reducing/reducing two-dimensional gel electrophoresis agreed
with results from the one-dimensional analysis. The intensity
of the SAR band was greatly decreased in the mdx protein
complement when compared with normal controls (Figures 1F
and 1G). The protein band representing SAR formed a vertical
immunolabel, indicative of a heterogeneous mixture of protein
species after chemical reduction. This has been described
previously for other microsomal proteins, such as the α2-subunit
of the transverse-tubular dihydropyridine receptor [32].
Standard two-dimensional gel electrophoresis using IEF in
the first dimension and SDS/PAGE in the second dimension
confirmed the drastic reduction of SAR in mdx muscles. Although
the overall silver-stained spot pattern was found to be relati-
vely comparable between the normal and dystrophic protein
complement, individual protein spots exhibited a different
intensity (Figures 2A and 2B). Therefore this result seemed to be
compatible with a proteomics-based approach towards identifying
specific proteins by digesting spots with trypsin, followed
by MS. Although our laboratory previously applied MS suc-
cessfully to identify digested fragments of microsomal muscle iso-
forms [37], this approach failed in the analysis of crude muscle
extracts owing to the high background levels of myofibrillar
elements (results not shown). In muscles, approximately half the
protein complement is represented by myosin, actin, troponin
and tropomyosin. Fragments of these abundant proteins prevent
a proper MS identification of the muscle Ca2+-binding proteins
of interest. Therefore databanks of standardized two-dimensional
gels, such as the ExPASy SWISS-2DPAGE mouse tissue library,
only list abundant proteins [38]. Although it was not possible
to identify a specific protein spot corresponding to SAR using
MS, immunoblotting with mAb C464.6 to the α1-subunit of
the Na+/K+-ATPase and mAb XIIC4 to SAR recognized their
respective antigens after two-dimensional gel electrophoresis. In
contrast with comparable levels of the α1-Na+/K+-ATPase in nor-
mal and mdx muscles (Figures 2C, 2D and 2G), SAR expression
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Figure 1 Immunoblot analysis of SAR expression in crude muscle extracts
(A, B) Immunoblots of total extracts from normal (lane 1, nor) and dystrophic mdx (lane 2)
skeletal muscles, labelled with antibodies to α1-Na+/K+-ATPase (α1-NKA) (A), as well as
SAR (B) and 53-SRGP (B). Molecular-mass standards (in kDa) are indicated on the left. (C–E)
Graphical representation of the immunoblot analysis (n = 5; *P < 0.05, unpaired t test). (F, G)
Immunoblot analyses of SAR in normal and dystrophic muscles respectively after diagonal non-
reducing/reducing two-dimensional gel electrophoresis (2D-NR/R). Molecular-mass standards
(in kDa) are indicated on the left and on the top of blots. Positions of immunodecorated proteins
are marked by the arrowhead.
was found to be significantly reduced in Dp427-deficient muscles
(Figures 2E, 2F and 2H).
Reduced expression of SAR in mdx SR
Before chemical cross-linking and immunoprecipitation analysis
of mdx microsomes, expression levels of membrane markers were
determined in the SR-enriched subcellular fraction. The mutant
status of the mdx preparation was confirmed by the complete
absence of the dystrophin band of 427 kDa apparent mass (Fig-
ures 3A and 3F). An antibody to the autosomal homologue of
Dp427, the 395 kDa dystrophin-related protein named utrophin
[39], revealed a comparable density of Up395 in normal and mdx
membranes (Figure 3B). As described previously, dystrophin-
associated glycoproteins, such as β-DG, were shown to be greatly
reduced in Dp427-deficient membranes (Figures 3C and 3G). No
marked differences in the expression of the fast SERCA1 isoform
Figure 2 Comparative two-dimensional immunoblot analysis of SAR
expression in normal and mdx muscle extracts
Silver-stained gels (A, B) and the corresponding immunoblots (C–F) of total extracts from
normal (A, C, E) and dystrophic mdx (B, D, F) skeletal muscles. Immunoblots were labelled
with antibodies to α1-NKA (C, D) and SAR (E, F). The relative position of immunodecorated
dots representing SAR and Na+/K+-ATPase are marked by arrowheads. The pH values of the
first dimension gel system and molecular-mass standards (in kDa) of the second dimension are
indicated on the top and on the left of the panels respectively. (G, H) Graphical representation
of the immunoblot analysis (n = 5; *P < 0.05, unpaired t test).
of the SR Ca2+-ATPase (Figures 3D and 3H) were detectable
by immunoblotting. Immunolabelling of the luminal SR Ca2+-
binding protein HRC [40] revealed no alteration in its relative
density in muscular dystrophy (Figure 3E).
Incubation of electrophoretically separated proteins with the
cationic carbocyanine dye named ‘Stains All’ specifically labels
major Ca2+-binding elements with a characteristic blue colour
[34], whereas other protein bands are stained in pink. As illustrated
in Figure 4(A), the ‘Stains All’ dye labelled a major microsomal
band at 63 kDa apparent mass and three minor bands in the 150–
220 kDa range. Figure 4(A) (lane 3) diagrammatically outlines
this staining pattern whereby the 63 kDa band corresponds
to the CSQ monomer. The upper three bands having lower
electrophoretic mobility represent overlapping bands consisting
of CLP-150, CLP-170, SAR, HRC and CLP-220. Whereas
‘Stains All’ labelling is a relatively crude labelling method,
immunoblotting using mAbs is a much more sensitive and specific
technique. This might explain why the ‘Stains All’ panel did
c© 2004 Biochemical Society
Reduced sarcalumenin expression in dystrophic muscles 483
Figure 3 Characterization of the microsomal fraction from normal and mdx skeletal muscles
(A–E) Immunoblots of microsomal membranes from normal (lane 1, nor) and dystrophic mdx (lane 2) skeletal muscles, labelled with antibodies to the Dp427 isoform of dystrophin (A), the Up395
isoform of utrophin (B), the dystrophin-associated glycoprotein β-DG (C), the fast SERCA1 isoform of the SR Ca2+-ATPase (D) and HRC (E). Molecular-mass standards (in kDa) are indicated on
the left. The position of immunodecorated proteins are marked by arrowheads. (F–H) Graphical representation of the immunoblot analysis (n = 5; *P < 0.05, unpaired t test).
not exhibit major differences in the expression pattern of Ca2+-
sequestrating proteins (Figure 4A), whereas the immunoblot
analysis of microsomal membranes clearly revealed a significant
reduction in CLPs (Figures 4B and 4D). The fast CSQ monomer
of 63 kDa apparent mass was shown to be not affected in mdx
membranes (Figures 4B and 4C).
Figure 5 illustrates the immunoblot analysis of 6-, 8- and
24-week-old mdx fibres. SAR expression was clearly reduced
in all the age groups studied (Figures 5A and 5C). Since
immunoblotting of younger specimens did not result in proper
staining patterns above background (results not shown), we
could not evaluate younger mdx fibres. This is due to the
difficulty in performing proper subcellular fractionation studies
using small sample sizes of developing mouse muscles and the
relatively low density of SAR in total tissue extracts. In contrast
with decreased SAR levels in older mdx fibres, the expression
of the surface α1-Na+/K+-ATPase was not changed in 6–24-
week-old mdx specimens (Figures 5B and 5D). Therefore both
the Na+/K+-ATPase and CSQ can be employed for convenient
internal standardization of immunoblots. This demonstrates that
the reduction in SAR and CLPs is not an artifact of the sub-
cellular fractionation technique, gel electrophoresis, transfer to
nitrocellulose, immunodecoration and/or the enhanced chemil-
uminescence detection method.
Complex formation between SAR and Ca2+-ATPase
Electron microscopical localization studies by Leberer et al.
[19] suggest a close neighbourhood relationship between SAR
and the SR Ca2+-ATPase. To evaluate whether these two SR
proteins exist in a tight complex as judged by biochemical criteria
and to determine whether the protein–protein interactions are
disturbed in the dystrophic phenotype, chemical cross-linking and
differential co-immunoprecipitation were performed.
Increasing concentrations of the hydrophobic probe DTSP
induced a shift of the SERCA1 band to a position with a drastically
reduced electrophoretic mobility (Figure 6A). In analogy, cross-
linker-stabilized oligomerization was also observed for SAR
(Figure 6B). A decrease in the monomeric bands of SAR and
SERCA1, as well as an increase in the oligomeric confor-
mation, was detected both in normal and mdx membranes.
Although the expression of SAR is drastically reduced in mdx
microsomes, the mass of the DTSP-stabilized oligomeric species
appears to be identical in normal and mdx muscles (Figure 6B).
The fact that the high-molecular-mass bands of both SR proteins
exhibited a potential overlap after cross-linking indicates the
existence of a supramolecular complex between SAR and
SERCA1. However, since the electrophoretic behaviours of pro-
tein assemblies with very high molecular mass do not exhibit a
linear relationship, the overlap between both the DTSP-induced
bands may be coincidental.
Hence, to validate the findings from the cross-linking ana-
lysis, differential co-immunoprecipitation was performed. Before
studying the potential complex between SAR and SERCA1, it was
examined whether this technique was capable of determining not
only protein–protein interactions, but also the relative reduction in
individual components owing to muscular dystrophy. As shown
in Figures 7(A) and 7(B), an antibody to LAM precipitated its
own antigen and another member of the dystrophin–glycoprotein
complex α-DG. The fact that α-DG is greatly reduced in mdx
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Figure 4 Reduced expression of CLPs in mdx microsomal fraction
A ‘Stains All’-labelled gel (A) and the corresponding immunoblot of microsomes from normal
(lane 1, nor) and dystrophic mdx (lane 2) skeletal muscles, labelled with an antibody to CSQ
(CSQf) and the CSQ-like proteins CLP-150, CLP-170 and CLP-220 (B). In (A), lane 3 is a
diagrammatic presentation of blue bands (BB) stained with the cationic carbocyanine dye ‘Stains
All’. The ‘Stains All’-labelled band of 63 kDa apparent mass is the CSQ monomer and the
high-molecular-mass bands represent CLP-220 and HRC at approx. 220 kDa, CLP-170 and
SAR at approx. 170 kDa and CLP-150 at approx. 150 kDa. Molecular-mass standards (in kDa)
are indicated on the left. Positions of immunodecorated proteins are marked by arrowheads.
(C, D) Graphical representation of the immunoblot analysis (n = 5; *P < 0.05, unpaired t test).
Figure 5 Reduced expression of SAR in mdx microsomal fraction
(A, B) Immunoblots of microsomes from normal (lane 1, nor) and 6-week-old (lane 2), 8-week-
old (lane 3) and 24-week-old (lane 4) dystrophic mdx skeletal muscles, labelled with antibodies
to SAR (A) and α1-NKA (B). Positions of immunodecorated proteins are marked by arrowheads.
(C, D) Graphical representation of the immunoblot analysis (n = 5; *P < 0.05, unpaired t test).
fibres but LAM is not markedly changed [7] is clearly reflected
by the immunoprecipitation results. In quantitative terms, results
from comparative immunoprecipitation experiments are not as
reliable as immunoblotting owing to potential variations in
the interactions between antigens and antibodies in different
starting materials. However, this method is widely employed
in a semi-quantitative approach. Using antibodies to SAR or
Figure 6 Chemical cross-linking analysis of SAR and Ca2+-ATPase in
normal and mdx microsomes
Immunoblots labelled with antibodies to the fast SERCA1 isoform of the SR Ca2+-ATPase
(A) and SAR (B) are shown. Lanes 1–5 (normal) and lanes 6–10 (mdx) represent 0, 25, 50,
200 and 500 µg of DTSP cross-linker (XL) per mg of microsomal membrane protein respectively.
Positions of immunodecorated monomers are indicated by arrowheads and DTSP-stabilized
oligomeric bands by open arrows. Molecular-mass standards (in kDa) are indicated on the left.
SERCA1, both their own antigen and the respective binding
partner were precipitated (Figures 7C–7F). This finding supports
the results from the cross-linking study. Furthermore, in mdx
membranes, both antibodies bound considerably less SAR when
compared with normal membranes (Figures 7C and 7F). This
result agrees with the reduced expression of SAR in mdx muscle as
shown above by one- and two-dimensional immunoblot analyses
(Figures 1, 2 and 5).
Decreased SAR levels in dystrophin-deficient muscle fibres
To investigate the expression of SAR on the single fibre level,
we performed indirect immunofluorescence microscopy. The
labelling of transverse cryosections with an antibody to the Dp427
isoform of dystrophin confirmed peripheral localization of this
membrane cytoskeletal element in normal muscle (Figure 8A)
and the mutant status of mdx fibres (Figure 8B). Blue DAPI
staining showed the peripheral position of nuclei in normal fibres
(Figures 8A and 8C) and the drastic increase in centrally located
myonuclei in dystrophin-deficient cells (Figures 8B and 8D).
For internal standardization of immunolabelling and to outline
the cellular periphery, tissue sections were co-incubated with
antibodies to LAM. In contrast with the relatively comparable
Rhodamine staining of LAM in the cell-surface structure, green
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Figure 7 Differential co-immunoprecipitation analysis of SAR and Ca2+-
ATPase in normal and mdx microsomes
Immunoblots of solubilized microsomes immunoprecipitated (IP) with antibodies to LAM
(A, B), SAR (C, D) and the fast SERCA1 isoform of the SR Ca2+-ATPase (E, F). Immunoblots
(IB) were labelled with antibodies to LAM (A), α-DG (B), SAR (C, F) and the SR Ca2+-ATPase
(D, E). Lanes 1 and 2, microsomal membranes isolated from normal control and dystrophic
mdx skeletal muscles respectively. Positions of immunodecorated proteins are marked by
arrowheads. Molecular-mass standards (in kDa) are indicated on the left.
fluorescein labelling of SAR was found to be greatly reduced in
mdx fibres (Figures 8C and 8D). The regular punctuated staining
pattern of SAR in the interior of normal fibres, representative
of its luminal SR localization, is not present in mdx muscles.
Instead, more patchy immunodecoration is visible in mdx fibres
(Figure 8D).
Therefore the results of our analysis of SAR expression using
one-dimensional immunoblotting of crude muscle extracts
(Figure 1), two-dimensional immunoblotting of crude muscle
extracts (Figure 2), immunoblotting of microsomes (Figure 5),
immunoprecipitation (Figure 7) and immunofluorescence micro-
scopy (Figure 8) agree with each other and they demonstrate
drastically decreased levels of this luminal SR Ca2+-binding
protein in muscular dystrophy.
DISCUSSION
Duchenne muscular dystrophy represents the most frequent
gender-specific disease of childhood [41]. Although the primary
abnormality was elucidated 17 years ago [42] and has certainly
led to a greatly improved diagnosis of muscular disorders [43],
this biomedical knowledge has not yet improved the quality of
life or life expectancy of dystrophic children. It is not known how
the absence of dystrophin leads to muscle weakness. Knowing the
general symptoms of end-stage pathology and having elucidated
the specific genetic defect in a neuromuscular disorder does
not necessarily lead to a comprehensive molecular and cellular
understanding of a muscle disease process. Clinical information
regarding the onset, progression and severity of symptoms, the
symmetry of muscular weakness, the involvement of other organs
and the patient’s family history is often of limited help in
the identification of the secondary pathophysiological pathways
leading to muscle degradation. Histopathological findings such
as abnormal variation in fibre diameter, rounded muscle cells,
central nucleation, the occurrence of necrotic and regenerating
cells and the infiltration of connective and fatty tissues usually
do not explain the molecular mechanisms underlying contractile
weakness. Thus, in addition to the genetic analysis of muscle
diseases, it is crucial to perform comprehensive pathobiochemical
analyses of diseased muscle specimens to identify secondary
defects, which may be exploited in future approaches to counteract
symptoms of muscular disorders [26,27].
Although the mdx mouse does not exhibit all symptoms
of severe human Duchenne muscular dystrophy, it is a well-
established model of the X-chromosome-linked muscle disease
and is widely employed in biomedical research [44]. In the
present study, we have analysed Dp427-deficient mdx skeletal-
muscle fibres and could demonstrate that expression of the luminal
SR Ca2+-binding protein SAR of 160 kDa apparent mass is
drastically reduced in muscular dystrophy and its SR domains
appear to be changed in Dp427-deficient fibres. SAR has been
postulated to function as an intraluminal ion transporter, in
addition to its physiological role as a Ca2+-buffering element
[19]. The regular punctuated staining pattern of SAR in the
interior of the normal fibre probably reflects its luminal SR
localization. In stark contrast, the patchy immunofluorescence
labelling of mdx fibres indicates a potential re-organization of
SAR domains within the complex SR membrane system. In
contrast, CSQ domains are not affected in mdx muscles [16].
This suggests that impaired Ca2+ buffering within the mdx SR
is caused by both reduced SAR expression and impaired CSQ
oligomerization [16,18]. Perhaps more importantly, the abnormal
domain formation of SAR indicates an impaired Ca2+ shuttling
between the Ca2+-uptake SERCA units and the major terminal
cisternae Ca2+-binding CSQ clusters via SAR. This finding might
be of potential importance for explaining the observed Ca2+-
induced myonecrosis in muscular dystrophy [45].
As shown in Scheme 1, the increase in sarcolemmal Ca2+-leak
channel expression after exercise-induced membrane rupturing
and natural membrane re-sealing appears to be the main factor
for the increase in cytosolic Ca2+ levels [11]. To what extent
the perturbation of Ca2+ homoeostasis affects all cytosolic
domains in end-stage muscular dystrophy is debatable. Most
probably, the cytosolic Ca2+ overload in Dp427-deficient muscle
cells is not of a global nature, but is restricted to the subsar-
colemmal domain [10]. Skeletal-muscle membranes that exhibit
a greatly reduced dystrophin–glycoprotein complex lose their
sarcolemmal integrity. This in turn causes a dramatic increase in
exercise-induced membrane rupturing [8]. During the natural pro-
cesses of cell-membrane resealing, these transient microruptures
c© 2004 Biochemical Society
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Figure 8 Immunofluorescence localization of SAR in mdx muscles
Cryosections labelled with antibodies to the Dp427 isoform of dystrophin (green) (A, B), SAR (green) (C, D) and LAM (red) (C, D). Nuclei were stained with the DNA-binding dye DAPI (blue) (A–D).
Skeletal-muscle specimens were taken from normal (A, C) and mdx (B, D) skeletal-muscle fibres. Sarcolemmal dystrophin staining was absent from mdx fibres. LAM staining was almost exclusively
found in the cellular periphery, and the punctuated labelling of SAR occurred mostly in the internal structures of normal fibres. In dystrophic muscles, immunodecoration of SAR showed an overall
reduction and a more patchy pattern. Scale bar, 40 µm.
allow for the insertion of Ca2+-leak channels into the dystro-
phic sarcolemma. Localized increases in Ca2+ contribute a
pathophysiological cycle of enhanced protease activity and Ca2+-
channel activation. This phenomenon is exacerbated by abnormal
Ca2+ cycling through the SR lumen [16] and possibly also the
mitochondria [46]. Impaired CSQ clustering [18] and reduced
SAR expression, as described in the present study, may both
contribute to decreased luminal Ca2+ buffering. The muscular
degeneration process might be amplified by increased free
cytosolic Ca2+ levels. Consequently, increased sarcolemmal Ca2+
fluxes seem to influence indirectly luminal SR Ca2+ cycling,
which is probably a major factor in the progressive functional
decrease in Dp427-deficient muscle cells. In this respect, our study
clearly supports the calcium hypothesis of muscular dystrophy
[10–13,16].
One of the most promising new ways of determining global
changes in diseases is biomedical proteome research using
high-resolution two-dimensional electrophoresis and MS for
the identification of abnormal protein expression patterns [47].
However, this approach does not cover many low-abundance
proteins, hydrophobic membrane elements, very basic com-
ponents and exceptionally large proteins involved in muscle
pathology [48]. Therefore the conventional identification of elec-
trophoretically separated muscle proteins using one- or two-dim-
ensional immunoblot analyses, as presented here, still represents
a powerful tool for the initial identification of the secondary
abnormalities leading to fibre destruction. For mdx, muscle
proteomics (using standard two-dimensional electrophoresis
of total muscle extracts) would not have led to the initial
identification of dystrophin as a primary abnormality for two
reasons: (i) the full-length skeletal-muscle isoform of dystrophin
has an apparent molecular mass of 427 kDa and therefore does not
properly transfer from the first-dimension IEF gel to the second-
dimension slab gel, and (ii) the Dp427 isoform of the mem-
brane cytoskeleton is a relatively low-abundance protein and does
not show up as a distinct protein spot on two-dimensional gels.
On the other hand, comparative subcellular fractionation studies,
using lectin agglutination methods for the affinity isolation
of muscle sarcolemma vesicles, clearly revealed the absence of
dystrophin from dystrophic surface membrane preparations
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Scheme 1 Overview of the calcium hypothesis of muscular dystrophy
The flow chart (A) and the diagram (B) integrate the findings of our analysis of SAR expression in dystrophin-deficient skeletal-muscle fibres into the well-established calcium hypothesis of muscular
dystrophy. Absence of the Dp427 isoform of dystrophin triggers a drastic reduction in dystrophin-associated proteins (DAP). Loss of the linkage between the actin membrane cytoskeleton (MC)
and the extracellular matrix (ECM) protein LAM results in increased exercise-induced membrane microrupturing. Subsequently, Ca2+-leak channels are introduced into the sarcolemma (SL) after
membrane resealing, which in turn triggers the influx of Ca2+ ions into the cytosol. This pathophysiological effect is exacerbated by an impaired Ca2+-buffering capacity of the SR. Both decreased
CSQ clustering and reduced expression of SAR, as shown in the present study, cause abnormal Ca2+ cycling through the lumen of the SR (A). The resulting increased cytosolic Ca2+ levels then
trigger Ca2+-induced proteolysis, which eventually leads to severe muscular weakness. (B) The complex interaction between various Ca2+-regulatory proteins and how disturbances in the luminal
Ca2+-cycling process may trigger impaired excitation–contraction coupling are shown. Direct physical coupling between the voltage-sensing dihydropyridine receptor (DHPR) of the transverse
tubules (TT) and the ryanodine receptor (RyR) of the junctional SR causes Ca2+ release into the cytosol and thereby troponin C (TnC)-mediated muscular contraction. Interactions between the RyR
and CSQ clusters are maintained by triadin (TRI). The energy-dependent re-uptake of Ca2+ ions into the SR lumen via the SERCA Ca2+ pumps triggers muscle relaxation. The luminal Ca2+-binding
element SAR is postulated to act as an ion shuttle between the Ca2+-pump units and the Ca2+-reservoir complex of the terminal cisternae, which consists mostly of CSQ clusters. In conjunction
with the overexpression of Ca2+-leak channels (CLC) in the dystrophic sarcolemma, decreased SAR levels and impaired CSQ aggregation may play a major role in abnormal Ca2+ homoeostasis in
muscular dystrophy.
[49]. This illustrates that conventional biochemical strategies
analysing subproteomes can be successfully employed in muscle
pathology and used to complement large-scale and high-through-
put proteome projects.
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